142 related articles for article (PubMed ID: 140697)
1. Inhibitory effect of YC8 leukaemia cell line on in vitro lymphocyte reactivity.
Biasi G; Collavo D; Colombatti A; Chieco-Bianchi L
Br J Cancer; 1977 May; 35(5):528-36. PubMed ID: 140697
[TBL] [Abstract][Full Text] [Related]
2. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of Moloney virus-induced tumors in CBA and A mice.
Ahituv A; Naor D; Sharon R; Tarcic N; Klein BY
Cancer Immunol Immunother; 1982; 14(1):16-26. PubMed ID: 6186365
[TBL] [Abstract][Full Text] [Related]
4. In vitro interaction between lymphocytes allogenic leukemic cells.
Biasi G; Collavo D; Colombatti A; Chieco-Bianchi L
Bibl Haematol; 1975 Oct; (43):34-6. PubMed ID: 134694
[No Abstract] [Full Text] [Related]
5. Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts.
Rodey GE; Sprader JC; Bortin MM
Cancer Res; 1974 Jun; 34(6):1289-94. PubMed ID: 4275007
[No Abstract] [Full Text] [Related]
6. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
Konda S; Nakao Y; Smith RT
Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
[No Abstract] [Full Text] [Related]
7. Lymphocyte responses to syngeneic antigens. I. Enhancement of the murine autologous mixed lymphocyte response by polyethylene glycol.
Ponzio NM
Cell Immunol; 1980 Feb; 49(2):266-82. PubMed ID: 6444367
[No Abstract] [Full Text] [Related]
8. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
Gillis S; Smith KA
J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003
[TBL] [Abstract][Full Text] [Related]
9. Isogeneic and allogeneic lymphocyte interactions may be controlled by cell surface immunoglobulin tropism.
Finke JH; Ponzio NM; Battisto JR
Cell Immunol; 1976 Oct; 26(2):284-94. PubMed ID: 135647
[No Abstract] [Full Text] [Related]
10. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
11. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
Ihle JN; Lee JC; Rebar L
J Immunol; 1981 Dec; 127(6):2565-70. PubMed ID: 6795277
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
Kumar V; Caruso T; Bennett M
J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914
[TBL] [Abstract][Full Text] [Related]
13. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
14. Circulation of lymphoid cells in mice infected with Friend leukemia virus.
Bainbridge DR; Bendinelli M
J Natl Cancer Inst; 1972 Sep; 49(3):773-81. PubMed ID: 4539617
[No Abstract] [Full Text] [Related]
15. Immunogenic and immunosuppressive components in soluble preparations from Moloney murine leukemia virus-induced tumor cells.
Brandchaft PB; Aoki T; Silverman TN
Int J Cancer; 1976 May; 17(5):678-85. PubMed ID: 57937
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.
Sensi M; Grazioli L; Parmiani G
Cancer Immunol Immunother; 1986; 21(3):199-204. PubMed ID: 2938737
[TBL] [Abstract][Full Text] [Related]
17. "Self-reactive" T cells. II. Transferred syngeneic lymphoblasts induce T "stimulator" cells in vivo, to which syngeneic T cells "respond" in a syngeneic MLC in vitro.
Reimann J; Diamantstein T
Immunobiology; 1980 Dec; 157(4-5):450-62. PubMed ID: 6450159
[TBL] [Abstract][Full Text] [Related]
18. Suppression of T cell-mediated immunity by tumor cells: immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors.
Ting CC; Rodrigues D; Ting RC; Wivel N; Collins MJ
Int J Cancer; 1979 Nov; 24(5):644-55. PubMed ID: 160896
[TBL] [Abstract][Full Text] [Related]
19. Production and main characteristics of a fetal calf serum-specific cell line that induces T and B cell differentiation.
Rubin B; Cooley MA; Le Borgne de Kaouel C; Taylor RB; Golstein P
Scand J Immunol; 1980; 12(5):401-9. PubMed ID: 6451031
[TBL] [Abstract][Full Text] [Related]
20. Effects of murine leukemia viruses on the function of dendritic cells.
Gabrilovich DI; Roberts MS; Harvey JJ; Botcherby M; Bedford PA; Knight SC
Eur J Immunol; 1993 Nov; 23(11):2932-8. PubMed ID: 8223870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
